| P50 | author | François Lauzier | Q75068964 |
| P2093 | author name string | Olivier Lesur | |
| | Bruno Lévy | |
| | Patrice Lamarre | |
| P2860 | cites work | Vasopressors for shock | Q24246657 |
| | Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 |
| | Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care | Q27860820 |
| | Serial evaluation of the SOFA score to predict outcome in critically ill patients | Q28191384 |
| | Deaths: preliminary data for 2003. | Q30985378 |
| | Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats | Q31126809 |
| | Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits | Q33206358 |
| | The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. | Q33872817 |
| | Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock | Q34145159 |
| | The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series | Q34340908 |
| | Arginine vasopressin in 316 patients with advanced vasodilatory shock. | Q36308724 |
| | Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats | Q40744813 |
| | Human vascular endothelial cells express oxytocin receptors | Q40968960 |
| | Circulating vasopressin levels in septic shock. | Q43465970 |
| | Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock | Q43617591 |
| | The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis | Q43655593 |
| | Beneficial effects of short-term vasopressin infusion during severe septic shock | Q43901842 |
| | Direct cardiac effects of vasopressin and their reversal by a vascular antagonist | Q44073616 |
| | Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study | Q44430966 |
| | High-dose vasopressin is not superior to norepinephrine in septic shock* | Q44647389 |
| | The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock | Q44686390 |
| | Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock | Q44779143 |
| | Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors | Q44798496 |
| | Effects of continuous vasopressin infusion in patients with septic shock | Q44922485 |
| | Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. | Q45037778 |
| | Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study | Q46691567 |
| | Serum vasopressin concentrations in critically ill patients | Q46902577 |
| | Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions | Q46950029 |
| | Early changes in organ function predict eventual survival in severe sepsis | Q47713060 |
| | Dose-response effects of pressor doses of arginine vasopressin on renal haemodynamics in the rat. | Q51766304 |
| | Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. | Q54179117 |
| | Effects of vasopressin on pulmonary and systemic vascular mechanics. | Q54343151 |
| | Sepsis in European intensive care units: results of the SOAP study. | Q54471944 |
| | American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 |
| | Renal microvascular effects of vasopressin and vasopressin antagonists | Q69946506 |
| | A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage | Q71737243 |
| | Low-dose vasopressin in the treatment of vasodilatory septic shock | Q73099859 |
| | Vasopressin deficiency contributes to the vasodilation of septic shock | Q73120268 |
| | Vasopressin pressor hypersensitivity in vasodilatory septic shock | Q73617085 |
| | Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries | Q74027410 |
| P433 | issue | 11 | |
| P921 | main subject | sepsis | Q183134 |
| | AVP | Q12009087 |
| | norepinephrine | Q186242 |
| | septic shock | Q1765564 |
| P304 | page(s) | 1782-1789 | |
| P577 | publication date | 2006-09-22 | |
| P1433 | published in | Intensive Care Medicine | Q15749164 |
| P1476 | title | Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial | |
| P478 | volume | 32 | |